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Objectives. Multiple technical diﬃculties are encountered when a multidisciplinary team of subspecialists begins a minimally-
invasive fetal cardiac interventional program. We describe the learning curve. Study Design. Ten pregnant sheep underwent
ultrasound-guided balloon valvuloplasty of the aortic valve. Team members and their roles remained constant through the trial.
The time between needle insertion and entrance of the left ventricle at the aortic root was recorded. F-test was used to assess
signiﬁcance (P ≤ .05). Results. The time required to accurately position the needle tip at the aortic root decreased signiﬁcantly
over the course of the trial, from 12 minutes with the ﬁrst attempt to one minute with the last (P = .003). Conclusion. A signiﬁcant
learning curve is encountered when a multidisciplinary team begins a minimally-invasive fetal cardiac intervention program.
However,technical proﬁciencycanbeachieved withpractice.Institutionsinterestedindevelopingsuchaprogramshouldconsider
practice in an animal model before proceeding to the human fetus.
1.Introduction
Balloon valvuloplasty for fetal critical aortic stenosis has
been shown to alter the developmental trajectory of some
fetuses from hypoplastic left heart syndrome (HLHS) toward
restored left ventricular growth [1–4]. Technical success
holds the promise of two ventricle circulation in the neonate,
thereby avoiding the need for three-stage palliation to single
ventricle circulation or cardiac transplant [4]. The fact
that this can be achieved through a single needle insertion
through the maternal abdomen into the fetal chest is
especially appealing in that it avoids the profound morbidity
associated with the diagnosis of HLHS in the neonate,
while exposing mother and fetus to minimal risk. There are
multiple technical challenges involved in performing fetal
valvuloplasty. Some of these diﬃculties have to do with com-
munication among team members during the navigation
of the needle through the maternal abdomen, uterine wall,
fetal chest wall, and into the left ventricle pointing directly
at the aortic root. While learning to function as a team,
the members of the interventional program must agree on
a standard orientation for ultrasound imaging that takes
into consideration the needle trajectory and target. Finally,
complications occur during fetal cardiac intervention such
as arrhythmia, hemopericardium, and cardiac tamponade
that require a rapid and coordinated response. Use of a
large animal training paradigm, typical for surgical training
on medical device implantation, could allow the team to
learn the technique, develop eﬀective communication, and
practice appropriate responses to complications.
We describe the learning curve encountered by a multi-
disciplinary team of maternal-fetal medicine, interventional
cardiology, and fetal echocardiography subspecialists during
the initiation of a minimally-invasive fetal cardiac interven-
tion program. Our aim is to demonstrate that technical
challenges are signiﬁcant but are surmountable. Practice in
a large animal training model should be considered before
proceeding to the human fetus.2 Minimally Invasive Surgery
2.MaterialsandMethods
2.1. Study Design. This study is a secondary analysis of
a trial comparing a computer-assisted navigational system
(CANav) to ultrasound-guided “freehand” insertion of an
operative needle into the left ventricle of the sheep fetus. In
that study, the time required to navigate the needle from the
maternal abdomen into the left ventricle using CANav was
compared to the time required to perform a similar function
without. The present study describes the time interval
during the “freehand” attempts over the course of the trial,
and represents the learning curve of the multidisciplinary
team.
2.2. Equipment. Based on the published methods for human
fetal cardiac intervention [4–8] and personal experience, we
selected needles, wires, and catheters currently in use in the
human fetus.
A standard thin-walled Cook 19-gauge intravascular
needle (DTN-19UT-11.5-M3, Cook International, Bloom-
ington,IN)wasused.Thisneedlecontainsasolidtrocarwith
an axi-symmetric, sharp tip and permits smooth passage
of a 0.014 inch diameter guide wire. An 18-gauge Cook
interventional needle with a unique external Echotip mark-
ings to enhance ultrasound visualization (G05045, 15cm
length,Hawkins-Atkinsblunttipneedle,CookInternational,
Bloomington, IN) was also evaluated. We used either a
standard ﬂoppy-tip 0.014
   guide wire (22339M, Floppy II,
GuidantCorporation)oratip-deﬂectingguidewire(STEER-
IT 535DSM014, Cordis Corporation, Miami Lakes, FL).
Finally, a standard 3mm outer diameter coronary angio-
plasty balloon (H7492062009300, 3.0mm balloon diameter,
9mm balloon length, Maverick Over-The-Wire, Boston
Scientiﬁc, Natick, MA or 563-FX030, 3.0 balloon diameter
and 10mm balloon length, Ninja FX, Cordis Corporation,
Miami Lakes, FL) was used for the procedures.
2.3. Animal Trials. All experiments using pregnant sheep
were performed under an approved Institutional Animal
Care and Use Protocol (no. 0612581) of the University of
Pittsburgh. We studied 10 pregnant ewes, two with twins
(n = 12 fetal sheep) at between 85 and 110 days of
a 145-day gestation [9].The newborn lamb and human
have comparable average weights (3.5kg) and we selected
a period in fetal lamb gestation when the average fetal
lamb aortic valve annulus and average left ventricular long
axis length are comparable to the 20-to-30 week gestation
human fetus. Pregnant ewes arrived from the supplier
approximately 3 days before the procedure and a complete
physical examination was performed prior to anesthesia and
instrumentation.
The research team for the fetal sheep cardiac interven-
tion trials included (1) a maternal-fetal medicine specialist
with intrauterine intervention experience, (2) a veterinary
anesthetist with 2 support staﬀ, (3) 2 pediatric cardiologists
trained in fetal cardiology, (4) a pediatric cardiologist who
specializes in technology development, and (5) a pediatric
cardiologist with interventional cardiology expertise. Prior
to the start of each procedure, the team reviewed the inter-
ventional technique and the role each member was to play.
Maternal body temperature was monitored using a
digital rectal probe and maintained between 36
◦Ca n d
37
◦C, using a warming blanket. Heart rate was monitored
using standard ECG electrodes and module. Pregnant sheep
were sedated with Ketamine (10mg/kg i.v.), intubated for
mechanical ventilation, and then anesthesia was continued
with isoﬂurane (2%) and 100% oxygen. Pavulon (0.1mg/kg
i.v.) was given to suppress spontaneous movement. Fluid-
ﬁlled intravascular catheters were placed in the carotid artery
v i ac u td o w nt om e a s u r ea r t e r i a lp r e s s u r ea n dw i t h d r a w
blood samples and in the jugular vein to infuse ﬂuids.
Intermittent blood samples were withdrawn to measure
blood gas content for acid-base status as an index of
adequacy of ventilatory support.
The maternal lower abdominal fur was shaved and
prewarmed ultrasound coupling gel was used for ultrasound
imaging. Each sheep fetus was imaged using a clinical ultra-
sound system (HD11, Phillips Medical Systems, Bothwell,
WA) and a curved array obstetrics ultrasound probe (C5-2,
PhillipsMedicalSystems,Bothwell,WA).Ageneralscreening
fetal ultrasound was performed to identify the presence of a
single or twin gestation and to determine the orientation of
each sheep fetus within the maternal abdomen. Optimizing
fetal positioning to allow for a percutaneous approach was
attemptedtransabdominally.Ifunsuccessful,laparotomywas
performed followed by uterine manipulation in order to
properly position the fetus (left side up). Time required to
position the fetus was not included in the trial. Prior to
starting the procedure, a single dose of atropine (1mg/kg)
was delivered to the fetal thigh as an intramuscular injection
to prevent fetal bradycardia.
Fetal cardiac ultrasound was performed to determine
the fetal heart rate, left ventricular short-axis and long-axis
dimensions (mm), aortic valve annulus diameter (mm), and
the presence or absence of pericardial ﬂuid. The midpoint
of the aortic valve and the left ventricular (LV) apex were
determined using alternating long-axis and four-chamber
views. These two points deﬁne an optimal trajectory for the
interventional needle path. Following a 2mm surgical skin
incision, the needle was advanced through the maternal skin
and uterine wall into the amniotic cavity under ultrasound
visualization. The trajectory of the trocar and needle were
continuously updated and displayed on the ultrasound
image. After conﬁrming that the needle trajectory remained
“on-path”, the needle was then advanced through the fetal
chest wall, fetal pericardium, fetal ventricular apex and into
the left ventricular cavity (Figure 2). Once the needle was
positioned within the LV cavity, the trocar was removed and
0.014
   guide wire and premounted coronary balloon were
advanced across the aortic valve (Seldinger technique) to
performballoonvalvuloplasty.Theballooncatheterwasthen
inﬂated during ultrasound imaging (Figure 3). Following
balloon deﬂation, the balloon and wire were withdrawn
through the needle taking care to maintain the tip of
the needle within the fetal left ventricle. Fetal intracardiac
atropine (0.1mg/kg) was given via the needle if bradycardia
developed during the procedure.Minimally Invasive Surgery 3
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Figure 1: Needle navigation time versus trial number. The time
required to accurately position the needle tip at the aortic root
decreased signiﬁcantly over the course of the trial, from 12 minutes
with the ﬁrst attempt to one minute with the last. P = .003, F-test.
2.4. Laparotomy. If an acceptable trajectory was not avail-
able due to an unfavorable fetal position, a small lateral
laparotomy incision was performed to allow manual repo-
sitioning of the fetus within the uterus and/or expose the
uterus for direct trocar and needle puncture. This surgical
procedure involved a vertical incision through the skin
and subcutaneous tissues to reach the peritoneal cavity.
Vascular structures were cauterized or ligated if transected.
The peritoneum was then opened to visualize the uterus.
Warmed, saline-soaked sponges were used to pack the
intestinefromtheoperativeﬁeld.Sterileultrasoundgelanda
sterileultrasoundtransducersheathwereusedontheuterine
surface to allow ultrasound imaging of the fetus.
All attempts to enter the fetal left ventricle (LV) were
successful. The time between initiation of needle insertion
and entrance of the LV at the aortic root was recorded as a
composite measure of team communication and decision-
making, and was the time interval recorded in the computer-
assisted navigation trial. Time to balloon inﬂation was
not recorded independently of needle insertion as it was
felt to be independent of the navigational component of
the procedure. In order to maximize use of the animals,
several attempts were made per animal. The time interval
between induction of anesthesia and needle insertion (with
or without laparotomy) was not recorded. Only attempts
without computer-assisted navigation were analyzed. F-test
was used to assess a signiﬁcant diﬀerence in the time to
complete this complex set of tasks (initial trial versus ﬁnal
trial, P ≤ .05).
3. Results
The time required to traverse the uterus, enter the fetal chest,
and accurately position the needle tip at the aortic root
decreased signiﬁcantly over the course of the trial, from 12
minutes with the ﬁrst attempt to one minute with the last
(P = .003) (Table 1 and Figure 1).T h et i m ed e c r e a s e db y
0.54 minutes per trial.
Figure 2: Illustration of the correct needle trajectory through the
maternal abdomen and into the fetal left ventricle at the apex.
Figure 3: Illustration of the correct needle placement to allow for
wire passage and balloon inﬂation across the aortic valve.
Table 1: Table summarizing trial number, week of the trial, animal
number, fetal position, need for laparotomy, and the time required
to navigate the needle to the correct position in the left ventricle.
Theoriginalcomputer-assistednavigationinvestigationinvolved24
trials. Of these, 8 were done “freehand, ” that is, without computer-
assisted navigation. These 8 trials are used in the current analysis.
Trial
no.
Week
no.
Animal
no. Position Lap
YES/NO
Time to
LV w/o
Navigation
522t w i n
A Transverse Yes 12
622t w i n
B Transverse Yes 11
10 3 3 Cephalic No 8
16 4 6 Cephalic No 1
18 4 7 Cephalic No 3
20 4 8 Cephalic No 3
21 4 8 Cephalic No 5
24 5 10 Transverse Yes 14 Minimally Invasive Surgery
Five of ten sheep (50%) required laparotomy for fetal
repositioning. Animals 2, 3, 6, 7, and 10 underwent both
computer-assisted and unassisted trials in an eﬀort to
maximize use of the animal.
4. Comments
Our study was designed to simulate, for training and equip-
ment validation purposes, human fetal cardiac intervention
as it is currently performed. The animals were surgically
prepped, sterile technique was used in a modern operating
suite, equipment is identical, and personnel involved in the
trialswerethosewhowillperformhumanfetalinterventions.
As the location, equipment and personnel remained rela-
tively constant throughout the trial; our results demonstrate
the learning curve of the team and not that of any one
individual.
There is a signiﬁcant learning curve encountered when
a multidisciplinary team of subspecialists begins a fetal
cardiac intervention program. The learning curve results
from a number of obstacles. First, members the group are
not necessarily used to working together during an invasive
procedure. Communication, teamwork, and cooperation
take time to develop.
Second, a standard ultrasound orientation is necessary
foraccuratesonographic guidance during theprocedure. For
instance, some fetal echocardiographers invert and/or ﬂip
the ultrasound image to mimic the orientation of pediatric
echocardiography. Obviously, this can lead to signiﬁcant
confusion among team members not familiar with this
orientation.
Third, unlike other ultrasound-guided intrauterine pro-
cedures, the needle trajectory in fetal cardiac intervention
must be precise. The target is ﬁxed within the maternal
abdomen and is approachable by only one narrow trajectory
in X, Y,a n dZ planes. We therefore developed a method
whereby the ultrasound probe is viewed in relation to the
face of a clock, where the reference indicator is 12:00; the
3:00, 6:00, and 9:00 positions logically follow. This allows
for ultrasound guidance only in relation to the ultrasound
probe and target and allows for continuous updating of
the needle path with the desired trajectory. Arbitrary and
confusing terms such as “more toward the left” are avoided.
This technique allows for accurate sonographic guidance
irrespective oftherelation between thedesired trajectory,the
maternal abdomen, and the fetal lie.
Af o u r t ho b s t a c l ei sf e t a lp o s i t i o n .A sw i t ha l ls u r g e r y ,
adequate exposure and positioning are essential to successful
intervention. Successful cardiac intervention requires precise
placement of the needle tip pointing directly at the aortic
root. If an adequate trajectory cannot be established, the
procedure will fail. Although it is tempting to attempt needle
placement percutaneously, maternal laparotomy with fetal
repositioning will more likely ensure a successful procedure.
Additionally, a failed percutaneous attempt can result in fetal
compromise, rendering subsequent attempts more diﬃcult.
Experience allows the development of judgment on whether
a percutaneous approach is achievable, which was a major
component of our learning curve. Overall, 50% of our sheep
required laparotomy for fetal repositioning, similar to the
rate reported elsewhere [4, 10].
Management of these obstacles contributes to eﬃcient
and successful catheter placement. We therefore chose the
interval between initiation of the trajectory and needle
placement in the left ventricle as a measure of teamwork,
communication and judgment. We elected to not analyze
catheter attempts using computer-assisted navigation, as
institutions developing interventional programs are unlikely
to have access to such technology. Even with computer-
assisted navigation, the main obstacles remain.
Finally, as with all surgical interventions, complications
will occur. Some of the complications our team encountered
included arrhythmias, hemopericardium, cardiac tampon-
ade, and equipment failure. Having witnessed and managed
these events in the animal model is likely to improve their
successful management in the human fetus.
There are several limitations to our study. The ﬁrst is
that it is a secondary analysis of a validation study which
compared the success of computer-assisted navigation to
that of “freehand” fetal cardiac intervention [8]. Analysis of
the learning curve was not the primary intent of the study.
Therefore, certain time intervals and outcomes that may
have supplemented this manuscript were not recorded. A
second limitation is fewer data points for time to LV without
navigation (n = 8) compared to that of with navigation
(n = 16). A third is that we used the same team for all
of the experiments. A comparable approach using the same
paradigm and a diﬀerent team would provide additional
validation. Finally, we could not randomize the gestational
age of the fetuses during the study. It is possible that fetal
gestation was an important determinant of the time to
complete intervention.
In summary, a signiﬁcant learning curve is encountered
when a multidisciplinary team of obstetric and pediatric
subspecialists begins a minimally-invasive fetal cardiac inter-
vention program. We advocate that institutions interested in
developing a cardiac intervention program should consider
practice in an animal model before proceeding to the human
fetus.
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